32 result(s)
Discover how gene-edited iPSCs create powerful 'disease-in-a-dish' models, and how Revvity's expert CRO services can accelerate your project.
Revvity’s Dharmacon™ CRISPR portfolio expands with validated CRISPR guide RNAs for complex but critical gene targets, as well as DNA cutting controls for screen normalization in sensitive assays.